The Canadian Innovation Exchange (CIX) has just announced its CIX Public Top 20 list and RepliCel Life Sciences (TSX: V.RP, Forum) has been named as part of this elite group of Canadian tech companies. The CIX Public Investor Day takes place at the MaRS Discovery District in Toronto, Ontario on November 18, 2015 and Stockhouse is proud to be a title sponsor. RepliCel, along with a host of industry experts and other CIX Public Top 20 recipients, will be presenting live and in person. If you wish to attend and want more information on CIX, click here.
RepliCel Life Sciences is a bio-tech play looking to revolutionize, among other things, the hair loss treatment market with a potentially permanent solution as well as bringing to market a ground-breaking proprietary and patented delivery device which looks to disrupt a multitude of treatment verticals. I got the chance to sit down with R. Lee Buckler, B. Ed, LLB, RepliCel VP Business and Corporate Development, to get a deep dive on RepliCel, it's innovative pipeline and its market potential. Have a listen.
--Gaalen Engen
https://twitter.com/gaalenengen